Literature DB >> 24468869

Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy.

Yukiko Morita1, Kazuhiro Kimura, Youichiro Fujitsu, Atsushi Enomoto, Shinji Ueno, Mineo Kondo, Koh-Hei Sonoda.   

Abstract

PURPOSE: To report a case of melanoma-associated retinopathy (MAR) in a Japanese patient found to have autoantibodies to transient receptor potential cation channel, subfamily M, member 1 (TRPM1). CASE: An 82-year-old man presented with blurred vision OS as well as night blindness and photopsia OU. Fundus photography, fluorescein angiography, and spectral domain-optical coherence tomography findings were essentially normal. Goldmann perimetry revealed a relative central scotoma, including the blind spot in the right eye, as well as a relative scotoma around a blind spot OS. The full-field scotopic electroretinograms showed a "negative-type" pattern OU, suggestive of extensive bipolar cell dysfunction. Systemic examination revealed that the patient had malignant melanoma of the anus with lung metastasis. Autoantibodies to TRPM1 were detected in the serum of the patient by immunoblot analysis. Vitreous opacity developed during follow-up. The visual symptoms and vitreous opacity of the patient were markedly improved after oral prednisolone therapy. The patient died as a result of widespread metastasis of the melanoma at 11 months after his first visit.
CONCLUSION: The present case is the first reported instance of MAR positive for autoantibodies to TRPM1 in an Asian patient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24468869     DOI: 10.1007/s10384-013-0300-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  23 in total

1.  Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Ann H Milam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

Review 2.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

Review 3.  TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function.

Authors:  Chieko Koike; Tomohiro Numata; Hiroshi Ueda; Yasuo Mori; Takahisa Furukawa
Journal:  Cell Calcium       Date:  2010-09-16       Impact factor: 6.817

4.  Ultrastructural localization and expression of TRPM1 in the human retina.

Authors:  Jan Klooster; Joyce Blokker; Jacoline B Ten Brink; Unga Unmehopa; Kees Fluiter; Arthur A B Bergen; Maarten Kamermans
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

5.  TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.

Authors:  Chieko Koike; Takehisa Obara; Yoshitsugu Uriu; Tomohiro Numata; Rikako Sanuki; Kentarou Miyata; Toshiyuki Koyasu; Shinji Ueno; Kazuo Funabiki; Akiko Tani; Hiroshi Ueda; Mineo Kondo; Yasuo Mori; Masao Tachibana; Takahisa Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

6.  TRPM1 mutations are associated with the complete form of congenital stationary night blindness.

Authors:  Makoto Nakamura; Rikako Sanuki; Tetsuhiro R Yasuma; Akishi Onishi; Koji M Nishiguchi; Chieko Koike; Mikiko Kadowaki; Mineo Kondo; Yozo Miyake; Takahisa Furukawa
Journal:  Mol Vis       Date:  2010-03-12       Impact factor: 2.367

7.  TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells.

Authors:  Catherine W Morgans; Jianmei Zhang; Brett G Jeffrey; Steve M Nelson; Neal S Burke; Robert M Duvoisin; R Lane Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-27       Impact factor: 11.205

8.  Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans.

Authors:  Zheng Li; Panagiotis I Sergouniotis; Michel Michaelides; Donna S Mackay; Genevieve A Wright; Sophie Devery; Anthony T Moore; Graham E Holder; Anthony G Robson; Andrew R Webster
Journal:  Am J Hum Genet       Date:  2009-10-29       Impact factor: 11.025

Review 9.  Paraneoplastic retinopathies and optic neuropathies.

Authors:  Jane W Chan
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

10.  TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness.

Authors:  Isabelle Audo; Susanne Kohl; Bart P Leroy; Francis L Munier; Xavier Guillonneau; Saddek Mohand-Saïd; Kinga Bujakowska; Emeline F Nandrot; Birgit Lorenz; Markus Preising; Ulrich Kellner; Agnes B Renner; Antje Bernd; Aline Antonio; Veselina Moskova-Doumanova; Marie-Elise Lancelot; Charlotte M Poloschek; Isabelle Drumare; Sabine Defoort-Dhellemmes; Bernd Wissinger; Thierry Léveillard; Christian P Hamel; Daniel F Schorderet; Elfride De Baere; Wolfgang Berger; Samuel G Jacobson; Eberhart Zrenner; José-Alain Sahel; Shomi S Bhattacharya; Christina Zeitz
Journal:  Am J Hum Genet       Date:  2009-11-05       Impact factor: 11.025

View more
  5 in total

1.  Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction.

Authors:  Wei-Che Hung; Hui-Chen Cheng; An-Guor Wang
Journal:  Doc Ophthalmol       Date:  2022-09-29       Impact factor: 1.854

2.  TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms.

Authors:  Robert M Duvoisin; Gaoying Ren; Tammie L Haley; Matthew H Taylor; Catherine W Morgans
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

3.  Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Authors:  Juliette Varin; Margaret M Reynolds; Nassima Bouzidi; Sarah Tick; Juliette Wohlschlegel; Ondine Becquart; Christelle Michiels; Olivier Dereure; Robert M Duvoisin; Catherine W Morgans; José-Alain Sahel; Quentin Samaran; Bernard Guillot; José S Pulido; Isabelle Audo; Christina Zeitz
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

Review 4.  Polymodal roles of transient receptor potential channels in the control of ocular function.

Authors:  Peter S Reinach; Weiwei Chen; Stefan Mergler
Journal:  Eye Vis (Lond)       Date:  2015-03-02

Review 5.  Ocular transient receptor potential channel function in health and disease.

Authors:  Peter S Reinach; Stefan Mergler; Yuka Okada; Shizuya Saika
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.